153 related articles for article (PubMed ID: 21565182)
1. The expression of BST2 in human and experimental mouse brain tumors.
Wainwright DA; Balyasnikova IV; Han Y; Lesniak MS
Exp Mol Pathol; 2011 Aug; 91(1):440-6. PubMed ID: 21565182
[TBL] [Abstract][Full Text] [Related]
2. Plasma membrane proteomics identifies bone marrow stromal antigen 2 as a potential therapeutic target in endometrial cancer.
Yokoyama T; Enomoto T; Serada S; Morimoto A; Matsuzaki S; Ueda Y; Yoshino K; Fujita M; Kyo S; Iwahori K; Fujimoto M; Kimura T; Naka T
Int J Cancer; 2013 Jan; 132(2):472-84. PubMed ID: 22729361
[TBL] [Abstract][Full Text] [Related]
3. Up-regulation of bone marrow stromal protein 2 (BST2) in breast cancer with bone metastasis.
Cai D; Cao J; Li Z; Zheng X; Yao Y; Li W; Yuan Z
BMC Cancer; 2009 Apr; 9():102. PubMed ID: 19338666
[TBL] [Abstract][Full Text] [Related]
4. Aberrant regulation of the BST2 (Tetherin) promoter enhances cell proliferation and apoptosis evasion in high grade breast cancer cells.
Sayeed A; Luciani-Torres G; Meng Z; Bennington JL; Moore DH; Dairkee SH
PLoS One; 2013; 8(6):e67191. PubMed ID: 23840623
[TBL] [Abstract][Full Text] [Related]
5. Promotion of BST2 expression by the transcription factor IRF6 affects the progression of endometriosis.
Li J; He Y; Qu Y; Ren C; Wang X; Cheng Y; Sun L; Zhang X; Zhang G
Front Immunol; 2023; 14():1115504. PubMed ID: 37143676
[TBL] [Abstract][Full Text] [Related]
6. Activation of FGD5-AS1 Promotes Progression of Cervical Cancer through Regulating BST2 to Inhibit Macrophage M1 Polarization.
Liu G; Du X; Xiao L; Zeng Q; Liu Q
J Immunol Res; 2021; 2021():5857214. PubMed ID: 34692852
[TBL] [Abstract][Full Text] [Related]
7. The Expression of BTS-2 Enhances Cell Growth and Invasiveness in Renal Cell Carcinoma.
Pham QT; Oue N; Yamamoto Y; Shigematsu Y; Sekino Y; Sakamoto N; Sentani K; Uraoka N; Tiwari M; Yasui W
Anticancer Res; 2017 Jun; 37(6):2853-2860. PubMed ID: 28551621
[TBL] [Abstract][Full Text] [Related]
8. Reduction of CD200 expression in glioma cells enhances microglia activation and tumor growth.
Wang CY; Hsieh YT; Fang KM; Yang CS; Tzeng SF
J Neurosci Res; 2016 Dec; 94(12):1460-1471. PubMed ID: 27629530
[TBL] [Abstract][Full Text] [Related]
9. CpG oligodeoxynucleotides potentiate the antitumor activity of anti-BST2 antibody.
Hiramatsu K; Serada S; Kobiyama K; Nakagawa S; Morimoto A; Matsuzaki S; Ueda Y; Fujimoto M; Yoshino K; Ishii KJ; Enomoto T; Kimura T; Naka T
Cancer Sci; 2015 Oct; 106(10):1474-8. PubMed ID: 26498112
[TBL] [Abstract][Full Text] [Related]
10. BST2/Tetherin inhibits hepatitis C virus production in human hepatoma cells.
Pan XB; Qu XW; Jiang D; Zhao XL; Han JC; Wei L
Antiviral Res; 2013 Apr; 98(1):54-60. PubMed ID: 23422647
[TBL] [Abstract][Full Text] [Related]
11. BST2 induced macrophage M2 polarization to promote the progression of colorectal cancer.
He X; Chen H; Zhong X; Wang Y; Hu Z; Huang H; Zhao S; Wei P; Shi D; Li D
Int J Biol Sci; 2023; 19(1):331-345. PubMed ID: 36594082
[No Abstract] [Full Text] [Related]
12. Significance of perivascular tumour cells defined by CD109 expression in progression of glioma.
Shiraki Y; Mii S; Enomoto A; Momota H; Han YP; Kato T; Ushida K; Kato A; Asai N; Murakumo Y; Aoki K; Suzuki H; Ohka F; Wakabayashi T; Todo T; Ogawa S; Natsume A; Takahashi M
J Pathol; 2017 Dec; 243(4):468-480. PubMed ID: 28888050
[TBL] [Abstract][Full Text] [Related]
13. Recruited brain tumor-derived mesenchymal stem cells contribute to brain tumor progression.
Behnan J; Isakson P; Joel M; Cilio C; Langmoen IA; Vik-Mo EO; Badn W
Stem Cells; 2014 May; 32(5):1110-23. PubMed ID: 24302539
[TBL] [Abstract][Full Text] [Related]
14. [CDK1 expression and effects of CDK1 silencing on the malignant phenotype of glioma cells].
Chen H; Huang Q; Zhai DZ; Dong J; Wang AD; Lan Q
Zhonghua Zhong Liu Za Zhi; 2007 Jul; 29(7):484-8. PubMed ID: 18069625
[TBL] [Abstract][Full Text] [Related]
15. BST2 Promotes Tumor Growth via Multiple Pathways in Hepatocellular Carcinoma.
Xu X; Wang Y; Xue F; Guan E; Tian F; Xu J; Zhang H
Cancer Invest; 2020 May; 38(5):329-337. PubMed ID: 32427495
[TBL] [Abstract][Full Text] [Related]
16. Nuclear FABP7 immunoreactivity is preferentially expressed in infiltrative glioma and is associated with poor prognosis in EGFR-overexpressing glioblastoma.
Liang Y; Bollen AW; Aldape KD; Gupta N
BMC Cancer; 2006 Apr; 6():97. PubMed ID: 16623952
[TBL] [Abstract][Full Text] [Related]
17. Bone marrow stromal cell antigen 2: Tumor biology, signaling pathway and therapeutic targeting (Review).
Yu H; Bian Q; Wang X; Wang X; Lai L; Wu Z; Zhao Z; Ban B
Oncol Rep; 2024 Mar; 51(3):. PubMed ID: 38240088
[TBL] [Abstract][Full Text] [Related]
18. BST2/CD317 counteracts human coronavirus 229E productive infection by tethering virions at the cell surface.
Wang SM; Huang KJ; Wang CT
Virology; 2014 Jan; 449():287-96. PubMed ID: 24418563
[TBL] [Abstract][Full Text] [Related]
19. Glioma stem cells are more aggressive in recurrent tumors with malignant progression than in the primary tumor, and both can be maintained long-term in vitro.
Huang Q; Zhang QB; Dong J; Wu YY; Shen YT; Zhao YD; Zhu YD; Diao Y; Wang AD; Lan Q
BMC Cancer; 2008 Oct; 8():304. PubMed ID: 18940013
[TBL] [Abstract][Full Text] [Related]
20. Impact of MACC1 on human malignant glioma progression and patients' unfavorable prognosis.
Hagemann C; Fuchs S; Monoranu CM; Herrmann P; Smith J; Hohmann T; Grabiec U; Kessler AF; Dehghani F; Löhr M; Ernestus RI; Vince GH; Stein U
Neuro Oncol; 2013 Dec; 15(12):1696-709. PubMed ID: 24220141
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
